HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure.

Abstract
Every cardiac pump has its own maximum performance, which denotes its pumping capability. The difference between the performance in the resting state and that at maximum is called pumping reserve. Cardiac pumping performance is therefore best quantified by its hydraulic power output. Cardiac pumping capability is predictive of the ultimate prognosis of patients in severe heart failure whereas pumping reserve is a major determinant of exercise capacity. The therapeutic efficacy of cardiotonic drugs used in the treatment of ambulant heart failure patients should be evaluated with reference to the way they alter the relation between cardiac pumping reserve and exercise capacity.
AuthorsL B Tan
JournalCardiovascular research (Cardiovasc Res) Vol. 21 Issue 8 Pg. 615-22 (Aug 1987) ISSN: 0008-6363 [Print] England
PMID3328649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cardiotonic Agents
  • Vasodilator Agents
Topics
  • Cardiotonic Agents (therapeutic use)
  • Exercise Therapy
  • Heart (physiopathology)
  • Heart Failure (drug therapy, physiopathology, rehabilitation)
  • Heart Function Tests (methods)
  • Humans
  • Oxygen Consumption (drug effects)
  • Physical Exertion (drug effects)
  • Prognosis
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: